Allegra and Penlac drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among people who take Allegra and Penlac. Common interactions include anxiety among females and dyspepsia among males.
The phase IV clinical study analyzes what interactions people who take Allegra and Penlac have. It is created by eHealthMe based on reports of 40 people who take Allegra and Penlac from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
40 people who take Allegra and Penlac together, and have interactions are studied.
What is Allegra?
Allegra has active ingredients of fexofenadine hydrochloride. It is often used in allergies. eHealthMe is studying from 68,485 Allegra users for its effectiveness, alternative drugs and more.
What is Penlac?
Penlac has active ingredients of ciclopirox. eHealthMe is studying from 461 Penlac users for its effectiveness, alternative drugs and more.
Number of Allegra and Penlac reports submitted per year:
Common Allegra and Penlac drug interactions by gender *:
- Femur fracture
- Bone disorder
- Decreased interest
- Foot deformity
- Decreased activity
- Decreased appetite
Common Allegra and Penlac drug interactions by age *:
- Actinic keratosis
- Arteriosclerosis coronary artery
- Balance disorder
- Bone density increased
- Bone disorder
- Infusion site haemorrhage
- Injection site extravasation
- Injection site nerve damage
- Injection site pain
- Injection site rash
- Limb discomfort
- Pain in extremity
- Heat intolerance
- Face oedema
- Rash erythematous
- Rash pruritic
- Urinary retention
- Foot deformity
- General physical health deterioration
- Hypertonic bladder
- Impaired healing
- Lip swelling
- Loose tooth
Common conditions people have *:
- Asthma: 5 people, 12.50%
- Osteoporosis (bones weak and more likely to break): 3 people, 7.50%
- Joint Pain: 3 people, 7.50%
- Sleep Disorder: 2 people, 5.00%
- Immunodeficiency: 2 people, 5.00%
- High Blood Pressure: 2 people, 5.00%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 5.00%
* Approximation only. Some reports may have incomplete information.
Do you take Allegra and Penlac?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of the 2 drugs:
Browse all drug interactions of Allegra and Penlac:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Allegra interactions:
Browse all interactions between Allegra and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Penlac interactions:
- Penlac and Aspirin: 109 reports
Browse all interactions between Penlac and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on fexofenadine hydrochloride and ciclopirox (the active ingredients of Allegra and Penlac, respectively), and Allegra and Penlac (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Allegra and Penlac.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Zinc Sulfate and Cortef drug interaction - 4 seconds ago
- Kyprolis and Lotemax drug interaction - 23 seconds ago
- Allopurinol and Osteomyelitis Chronic - 29 seconds ago
- Clonidine and Calan drug interaction - 40 seconds ago
- Steatorrhea in Omeprazole, how severe and when it was recovered? - a minute ago
- Probiotic and Lomotil drug interaction - a minute ago
- Potassium Chloride and Urosepsis - a minute ago
- Finasteride and Azilect drug interaction - a minute ago
- Idiopathic Thrombocytopenic Purpura and Clostridium Difficile Colitis - a minute ago
- Carafate and Levothyroxine Sodium drug interaction - a minute ago